Data / Drug companies / Actavis Pharma, Inc.
Actavis Pharma, Inc.: 18 products in the FDA NDC directory, labeler code 0472
Actavis Pharma, Inc. (labeler code 0472) lists 18 products in the FDA National Drug Code Directory, covering 16 finished drugs by generic name. By type: 18 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on April 23, 2021.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 0472
- Products in commercial distribution
- 18
- Packages
- 29
- Finished drugs by generic name
- 16
- Prescription products
- 18
- Over the counter products
- 0
- Flagged as original packager
- 17 of 17 products that carry the flag
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 5
- Earliest marketing start
- January 18, 1995
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 17 | 94.4% |
| Authorized generics (NDA) | 1 | 5.6% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 18 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Betamethasone dipropionate | 3 | 27 |
| Miconazole nitrate | 1 | 101 |
| Acyclovir | 1 | 70 |
| Tretinoin | 1 | 28 |
| Adapalene | 1 | 34 |
| Desoximetasone | 1 | 14 |
| Diclofenac sodium | 1 | 109 |
| Ibuprofen | 1 | 190 |
| Desonide | 1 | 15 |
| Griseofulvin | 1 | 6 |
| Clobetasol propionate | 1 | 40 |
| Clindamycin phosphate and tretinoin | 1 | 4 |
| Nystatin | 1 | 40 |
| Levetiracetam | 1 | 87 |
| Clotrimazole and betamethasone dipropionate | 1 | 15 |
| Mesalamine | 1 | 41 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Suspension | 3 | 16.7% |
| Cream | 3 | 16.7% |
| Gel | 3 | 16.7% |
| Ointment | 3 | 16.7% |
| Suppository | 2 | 11.1% |
| Lotion | 2 | 11.1% |
| Solution | 1 | 5.6% |
| Ointment, augmented | 1 | 5.6% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Mesalamine | 0472-1915 | Suppository | Generic drugs (ANDA) | April 23, 2021 |
| Ibuprofen | 0472-2002 | Suspension | Generic drugs (ANDA) | July 16, 2018 |
| Desoximetasone | 0472-0479 | Ointment | Generic drugs (ANDA) | November 21, 2016 |
| Clindamycin Phosphate and Tretinoin | 0472-1790 | Gel | Generic drugs (ANDA) | July 5, 2016 |
| Diclofenac Sodium | 0472-1783 | Gel | Generic drugs (ANDA) | May 19, 2016 |
| Adapalene | 0472-0126 | Gel | Generic drugs (ANDA) | October 27, 2014 |
| Clobetasol Propionate | 0472-0404 | Lotion | Generic drugs (ANDA) | January 2, 2012 |
| Desonide | 0472-0803 | Lotion | Generic drugs (ANDA) | May 28, 2009 |
| Levetiracetam | 0472-0235 | Solution | Generic drugs (ANDA) | January 15, 2009 |
| Griseofulvin | 0472-0013 | Suspension | Generic drugs (ANDA) | July 26, 2007 |
| Clotrimazole and Betamethasone Dipropionate | 0472-0379 | Cream | Generic drugs (ANDA) | December 16, 2003 |
| Betamethasone Dipropionate | 0472-0380 | Cream | Generic drugs (ANDA) | September 3, 2002 |
| Nystatin | 0472-0166 | Ointment | Generic drugs (ANDA) | September 3, 2002 |
| Acyclovir | 0472-0082 | Suspension | Generic drugs (ANDA) | September 3, 2002 |
| Tretinoin | 0472-0117 | Cream | Authorized generics (NDA) | April 20, 1998 |
| Betamethasone Dipropionate | 0472-0381 | Ointment | Generic drugs (ANDA) | February 1, 1997 |
| Betamethasone Dipropionate | 0472-0382 | Ointment, augmented | Generic drugs (ANDA) | September 1, 1995 |
| Miconazole Nitrate | 0472-1738 | Suppository | Generic drugs (ANDA) | January 18, 1995 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.